On the other hand, González-Rodríguez et al. found no significant changes in BECN1 protein expression in liver tissue of MASLD patients, despite the aforementioned decrease in its mRNA levels [76]. Here, BECN1 is linked to metabolic dysfunction-associated steatotic liver disease.